Our results suggest that inhibition of FKBP4 induces a cell cycle arrest in triple-negative breast cancer cells through down-regulation of the PI3K/Akt signaling activity, resulting in Cyclin D1 downregulation. The gene discussed is CCND1; the disease is triple-negative breast carcinoma.